Leadership team

Wound Solutions leadership represents a broad base of experience in biopharmaceutical/ medical device development and commercialization. Our strategy is to grow the company and its vision using an experienced management team whilst outsourcing development and advisory activity to key partners who are world leaders in their areas of expertise.

This business-focussed resource strategy has achieved a high speed of product development and growth with minimal investment, a rarity in the medical innovation industry.

Management Team

Richard Nagle
CEO
Sarah Beeby
COO
Alan Boyce
VP, Strategic Partnerships
Miles Jordan
Product Development Manager

Board

Dr. Anthony Martin
Chairman
Richard Nagle
CEO
Sarah Beeby
COO
Simon Yaxley
NED
Julian Lee
Co-founder, NED
Richard Lyman
NED

Dr. Anthony Martin - Chairman

Chairman, Safeguard Biosystems Holdings Ltd. Non-Executive Chairman Molecular Insight Pharmaceuticals Inc (NASDAQ) and Sphere Medical Ltd. Long history of creating substantial value in the Life Science arena. Most recently as Chairman of NeuTec Pharma plc (AIM), sold to Novartis (£305 million).